- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 4.5 Form of Warrant Agency Agreement Between Dermata Therapeutics
- 4.7 Form of Pre-funded Warrant
- 4.8 Common Stock Purchase Warrant
- 5.1 Opinion of Lowenstein Sandler LLP
- 10.9 Second Amendment to Employment Agreement
- 10.11 First Amendment to Employment Agreement
- 10.13 First Amendment to Employment Agreement
- 23.1 Consent
- EX-FILING FEES Filing Fees
- Download Excel data file
- View Excel data file
- 29 Dec 22 RW Registration withdrawal request
- 7 Feb 22 S-1/A IPO registration (amended)
- 4 Feb 22 FWP Free writing prospectus
-
4 Feb 22 S-1 IPO registration
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 and related prospectus of our report dated April 2, 2021 (except for the effects of the reverse stock split described in Note 3 and the subsequent events described in Note 13 as to which the date is July 9, 2021), with respect to the financial statements of Dermata Therapeutics, Inc. (Company) as of December 31, 2020 and 2019 and for the two years then ended (which report includes an explanatory paragraph regarding the existence of substantial doubt about the Company’s ability to continue as a going concern), and to the reference to us under the heading “Experts” in the prospectus which is part of this Registration Statement.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
February 4, 2022